161 related articles for article (PubMed ID: 31055114)
1. Chitosan sponges as a sustained release carrier system for the prophylaxis of orthopedic implant-associated infections.
Pawar V; Bulbake U; Khan W; Srivastava R
Int J Biol Macromol; 2019 Aug; 134():100-112. PubMed ID: 31055114
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-polycaprolactone blend sponges for management of chronic osteomyelitis: A preliminary characterization and in vitro evaluation.
Pawar V; Srivastava R
Int J Pharm; 2019 Sep; 568():118553. PubMed ID: 31344444
[TBL] [Abstract][Full Text] [Related]
3. Cefuroxime conjugated chitosan hydrogel for treatment of wound infections.
Pawar V; Dhanka M; Srivastava R
Colloids Surf B Biointerfaces; 2019 Jan; 173():776-787. PubMed ID: 30384275
[TBL] [Abstract][Full Text] [Related]
4. Hydrophobic chitosan sponges modified by aluminum monostearate and dehydrothermal treatment as sustained drug delivery system.
Yodkhum K; Phaechamud T
Mater Sci Eng C Mater Biol Appl; 2014 Sep; 42():715-25. PubMed ID: 25063173
[TBL] [Abstract][Full Text] [Related]
5. Polymicrobial Biofilm Inhibition Effects of Acetate-Buffered Chitosan Sponge Delivery Device.
Jennings JA; Beenken KE; Parker AC; Smith JK; Courtney HS; Smeltzer MS; Haggard WO
Macromol Biosci; 2016 Apr; 16(4):591-8. PubMed ID: 26756211
[TBL] [Abstract][Full Text] [Related]
6. Chitosan sponges to locally deliver amikacin and vancomycin: a pilot in vitro evaluation.
Noel SP; Courtney HS; Bumgardner JD; Haggard WO
Clin Orthop Relat Res; 2010 Aug; 468(8):2074-80. PubMed ID: 20352389
[TBL] [Abstract][Full Text] [Related]
7. The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier.
Lee YM; Park YJ; Lee SJ; Ku Y; Han SB; Klokkevold PR; Chung CP
J Periodontol; 2000 Mar; 71(3):418-24. PubMed ID: 10776929
[TBL] [Abstract][Full Text] [Related]
8. Norfloxacin-loaded chitosan sponges as wound dressing material.
Denkbaş EB; Oztürk E; Ozdemir N; Keçeci K; Agalar C
J Biomater Appl; 2004 Apr; 18(4):291-303. PubMed ID: 15070516
[TBL] [Abstract][Full Text] [Related]
9. Innovative Vancomycin-Loaded Hydrogel-Based Systems - New Opportunities for the Antibiotic Therapy.
Florczyk A; Krajcer A; Wójcik K; Lewandowska-Łańcucka J
Int J Nanomedicine; 2024; 19():3991-4005. PubMed ID: 38720939
[TBL] [Abstract][Full Text] [Related]
10. Chitosan derivatives-based films as pH-sensitive drug delivery systems with enhanced antioxidant and antibacterial properties.
Affes S; Aranaz I; Acosta N; Heras Á; Nasri M; Maalej H
Int J Biol Macromol; 2021 Jul; 182():730-742. PubMed ID: 33836191
[TBL] [Abstract][Full Text] [Related]
11. Preliminary investigation of crosslinked chitosan sponges for tailorable drug delivery and infection control.
Parker AC; Jennings JA; Bumgardner JD; Courtney HS; Lindner E; Haggard WO
J Biomed Mater Res B Appl Biomater; 2013 Jan; 101(1):110-23. PubMed ID: 22997172
[TBL] [Abstract][Full Text] [Related]
12. Release of vancomycin and teicoplanin from a plasticized and resorbable gelatin sponge: in vitro investigation of a new antibiotic delivery system with glycopeptides.
Drognitz O; Thorn D; Krüger T; Gatermann SG; Iven H; Bruch HP; Muhl E
Infection; 2006 Feb; 34(1):29-34. PubMed ID: 16501900
[TBL] [Abstract][Full Text] [Related]
13. Preliminary evaluation of local drug delivery of amphotericin B and in vivo degradation of chitosan and polyethylene glycol blended sponges.
Parker AC; Rhodes C; Jennings JA; Hittle L; Shirtliff M; Bumgardner JD; Haggard WO
J Biomed Mater Res B Appl Biomater; 2016 Jan; 104(1):78-87. PubMed ID: 25615516
[TBL] [Abstract][Full Text] [Related]
14. Blended Chitosan Paste for Infection Prevention: Preliminary and Preclinical Evaluations.
Berretta JM; Jennings JA; Courtney HS; Beenken KE; Smeltzer MS; Haggard WO
Clin Orthop Relat Res; 2017 Jul; 475(7):1857-1870. PubMed ID: 28097503
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity and drug release of chitosan sponge containing doxycycline hyclate.
Phaechamud T; Charoenteeraboon J
AAPS PharmSciTech; 2008; 9(3):829-35. PubMed ID: 18626774
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and in vitro release study of drug-loaded sodium carboxy-methylcellulose/chitosan composite sponge.
Cai B; Zhong T; Chen P; Fu J; Jin Y; Liu Y; Huang R; Tan L
PLoS One; 2018; 13(10):e0206275. PubMed ID: 30346976
[TBL] [Abstract][Full Text] [Related]
17. Characterization of local delivery with amphotericin B and vancomycin from modified chitosan sponges and functional biofilm prevention evaluation.
Parker AC; Beenken KE; Jennings JA; Hittle L; Shirtliff ME; Bumgardner JD; Smeltzer MS; Haggard WO
J Orthop Res; 2015 Mar; 33(3):439-47. PubMed ID: 25408519
[TBL] [Abstract][Full Text] [Related]
18. In vivo degradation and release kinetics of chloramphenicol-loaded poly(D,L)-lactide sponges.
Taş C; Kozluca A; Onur MA; Tümer A; Vahapoğlu H; Zareie MH; Gunning PA; Pişkin E
Tissue Eng; 1998; 4(4):353-63. PubMed ID: 9916168
[TBL] [Abstract][Full Text] [Related]
19. Optimization of biodegradable sponges as controlled release drug matrices. I. Effect of moisture level on chitosan sponge mechanical properties.
Foda NH; El-laithy HM; Tadros MI
Drug Dev Ind Pharm; 2004 Apr; 30(4):369-79. PubMed ID: 15132179
[TBL] [Abstract][Full Text] [Related]
20. Chitosan nanoparticles and povidone iodine containing alginate gel for prevention and treatment of orthopedic implant associated infections.
Pawar V; Topkar H; Srivastava R
Int J Biol Macromol; 2018 Aug; 115():1131-1141. PubMed ID: 29727653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
